In 2014, during my first pregnancy, I felt happy and healthy almost all the time.
Exploring the companies and themes that make up this emerging and exciting new sector
MindMed Announces Chief Executive Officer Transition
JR Rahn is stepping down as MindMed's CEO, to be replaced by Chief Development Officer, Robert Barrow.
Are Psychedelics The Ultimate Brain-Repair Drugs?
Psychedelic drugs increasingly appear to be powerful medicinal tools to rebuild broken brains.
Red Light Holland Closes Acquisition of Cutting Edge Silicon Valley Applied Sciences Company Radix Motion, Becoming a Leader in Psychedelic Technology
Red Light Holland's new tech acquisition is intended to help optimize psychedelics dosing.
Optimi Health Announces Product Distribution Agreement with Vitasave
Optimi Health's new distribution agreement with Vitasave provides retail access to two of Canada's largest urban markets.
Seattle City Council Promotes Psychedelics As Potential Tool Against Opioid Epidemic
Seattle lawmakers on Monday sent a letter to members of a local task force focused on the opioid overdose epidemic, imploring the group to investigate the therapeutic potential of psychedelics like ayahuasca and ibogaine in curbing addiction.
Field Trip Virtually Opens The Market
Field Trip Health has uplisted to the TSX in Canada.
Psilocybin therapy appears to be at least as effective as a leading conventional antidepressant
Psilocybin, the active compound in magic mushrooms, may be at least as effective as selective serotonin reuptake inhibitors, the leading type of antidepressant medication, according to research published in the New England Journal of Medicine.
American Support For And Understanding Of Psychedelic Drugs Continues To Broaden
A Psychedelic Drug Revolution is underway to address the Mental Health Crisis. As with all revolutions, we are seeing a rapid shift in attitudes.
Increasing Interest in Psychedelics for Medical Purposes
Investors are always looking for hot new markets to invest in.
New York Bill Would Create State-Sponsored Psychedelics Research Institute
A New York lawmaker introduced a bill on Tuesday that would require the state to establish an institute to research the therapeutic potential of psychedelics.
Feds Should Work With—Not Against—States That Legalize Psychedelics, Government Health Official Says
Oregon’s move to legalize psilocybin mushrooms for therapeutic use should signal to the federal government that it needs to engage with jurisdictions that pursue such reforms and aid in the development of regulatory frameworks, a federal health official says.